Chang-Gung Further Adopts Bruker Daltonics' ClinProt Solution

The Chang-Gung Memorial Hospital (CGMH) has made a significant additional investment in mass-spectrometry instrumentation from Bruker Daltonics. CGMH has already successfully implemented Bruker Daltonics ClinProt system for MALDI-TOF (matrix assisted laser desorption ionization time-of-flight) mass spectrometry-based clinical proteomics and biomarker analysis in 2004 at their hospital in Linkou. CGMH will now further expand the use of these clinical diagnostics research platforms and will mirror the ClinProt solution at their hospital in Kaohsiung.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050404005400&newsLang=en)